MedX Health Corp. (TSXV MDX) Revenue and Competitors
Employee Data
- MedX Health Corp. (TSXV MDX) has 10 Employees.
- MedX Health Corp. (TSXV MDX) grew their employee count by 0% last year.
MedX Health Corp. (TSXV MDX)'s People
Name | Title | Email/Phone |
---|
MedX Health Corp. (TSXV MDX) Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 36 | -10% | N/A | N/A |
#2 | $15M | 84 | -6% | N/A | N/A |
#3 | N/A | 10 | 0% | N/A | N/A |
#4 | $3.5M | 118 | 42% | N/A | N/A |
#5 | $35M | 275 | -21% | N/A | N/A |
#6 | N/A | 14 | -7% | N/A | N/A |
#7 | N/A | 36 | -10% | N/A | N/A |
#8 | N/A | 6 | 0% | N/A | N/A |
#9 | N/A | 34 | 31% | N/A | N/A |
What Is MedX Health Corp. (TSXV MDX)?
MedX Health Corp. (TSXV: MED) is a leading medical device and software company focused on skin cancer with its DermSecure™ telemedicine platform, utilizing its SIAscopy technology. SIAscopy is also imbedded in its products SIAMETRICS™, SIMSYS™, and MoleMate™, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are Health Canada, FDA (US), ARTG and CE cleared for use in Canada, the US, Australia, New Zealand, the European Union and Turkey. MedX also designs, manufactures and distributes quality photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. www.medxhealth.com.
keywords:N/AN/A
Total Funding
10
Number of Employees
N/A
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0M | 10 | 0% | N/A |
#2 | $1M | 11 | N/A | N/A |
#3 | $6.8M | 11 | -69% | $39.6M |
#4 | $1M | 11 | -35% | N/A |
#5 | $1M | 12 | -14% | N/A |